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        Idiopathic pulmonary fi  brosis (IPF) is a chronic, 
lethal interstitial lung disease of unknown cause. 
The disease is characterized by scattered fi  brotic 
lesions in various stages of progression (  1  ). The 
sentinel morphological lesion is the fi  broblastic 
focus, which is composed of fi  broblasts in a type I 
collagen  –  rich matrix (  2  ). Evidence for the criti-
cal role of the fi  broblast in the relentless progres-
sion of IPF is prima facie: this is the cell that 
proliferates and deposits type I collagen in the 
alveolar wall, distorting alveolar architecture and 
impairing gas exchange (  2  –  5  ). Although recent 
studies support the theory that IPF fi  broblasts 
harbor intrinsic alterations of key components of 
their cellular machinery, large gaps in knowledge 
remain regarding the mechanisms conferring 
IPF fi  broblasts with the capacity to proliferate and 
persist in a setting where normal fi  broblasts dis-
play the tightly regulated proliferation essential 
for physiological repair (  6  –  12  ). 
  The molecular mechanisms regulating fi  bro-
blast proliferation on collagen matrices are com-
ing into focus. Seminal studies in the 1980s and 
1990s demonstrated that polymerized (fi  brillar) 
collagen, the natural form of type I collagen 
found in tissues, acts as a negative regulator of fi  -
broblast proliferation, whereas monomeric col-
lagen supports fi  broblast proliferation (  13  –  15  ). 
On the basis of this work, fi  broblast interaction 
with polymerized collagen is believed to pro-
vide an important physiological mechanism to 
limit fi  broproliferation after tissue injury. Inte-
grins mediate cellular interactions with the extra-
cellular matrix and are at the apex of signaling 
pathways that modulate key components of the 
cellular proliferative machinery (  16  –  26  ). Fibro-
blast interactions with type I collagen are medi-
ated predominantly by the     2    1 integrin (  19  ). 
In this study, we demonstrate that     1 integrin  –
  polymerized collagen interaction in normal 
fi  broblasts activates the negative growth regula-
tor, tumor suppressor phosphatase and tensin 
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    Idiopathic pulmonary fi  brosis (IPF) is a relentlessly progressive lung disease in which fi  bro-
blasts accumulate in the alveolar wall within a type I collagen  –  rich matrix. Although lung 
fi  broblasts derived from patients with IPF display durable pathological alterations in prolif-
erative function, the molecular mechanisms differentiating IPF fi  broblasts from their normal 
counterparts remain unknown. Polymerized type I collagen normally inhibits fi  broblast 
proliferation, providing a physiological mechanism to limit fi  broproliferation after tissue 
injury. We demonstrate that     1 integrin interaction with polymerized collagen inhibits 
normal fi  broblast proliferation by suppression of the phosphoinositide 3-kinase (PI3K)  –  Akt  –
  S6K1 signal pathway due to maintenance of high phosphatase activity of the tumor sup-
pressor phosphatase and tensin homologue (PTEN). In contrast, IPF fi  broblasts eluded this 
restraint, displaying a pathological pattern of     1 integrin signaling in response to polymer-
ized collagen that leads to aberrant activation of the PI3K  –  Akt  –  S6K1 signal pathway caused 
by inappropriately low PTEN activity. Mice defi  cient in PTEN showed a prolonged fi  broprolif-
erative response after tissue injury, and immunohistochemical analysis of IPF lung tissue 
demonstrates activation of Akt in cells within fi  brotic foci. These results provide direct 
evidence for defective negative regulation of the proliferative pathway in IPF fi  broblasts and 
support the theory that the pathogenesis of IPF involves an intrinsic fi  broblast defect. 1660 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
PI3K  –  Akt signal pathway function (  20  –  22  ). We examined 
activation of the PI3K  –  Akt pathway in response to interaction 
with collagen in both short-term adhesion and long-term 
proliferation assays. When serum-starved control fi  broblasts 
attach to monomeric collagen, the level of Akt phosphorylation 
increases in a time- and PI3K-dependent fashion, along with 
phosphorylation of the downstream kinase S6K1 (  Fig. 2 A  ).   
  The     2    1 integrin is a major type I collagen receptor (  19  ). 
To assess the importance of     2    1 in mediating activation of 
Akt in response to fi  broblast attachment to monomeric collagen, 
homologue (PTEN), whereas in IPF fi  broblasts this negative 
feedback mechanism is defective, enabling these cells to circum-
vent the negative proliferative eff  ects of polymerized collagen. 
    RESULTS   
  IPF fi  broblasts display enhanced proliferation 
on polymerized collagen matrices 
  Previous studies demonstrate that polymerized collagen in-
hibits smooth muscle cell and fi  broblast proliferation, whereas 
proliferation is supported on monomeric collagen (  13  –  15  ). IPF 
is characterized by the proliferation of fi  broblasts in fi  brotic 
foci that contain bundles of polymerized type I collagen (  2  –  5  ). 
We therefore examined the integrity of this negative feedback 
loop in IPF fi  broblasts. Compared with monomeric collagen, 
polymerized collagen markedly inhibited control fi  broblast 
proliferation. As controls, we used lung fi  broblasts derived 
from histologically normal lungs and fi  broblasts derived from 
diseased lung tissue from a patient with chronic obstructive 
pulmonary disease. In contrast, polymerized collagen was much 
less eff  ective in inhibiting IPF fi  broblast proliferation than that 
of control fi  broblasts, as assessed by cell number (  Fig. 1 A  ) and 
BrdU incorporation (  Fig. 1 B  ).   These data unveil a relaxation 
of negative growth control in IPF fi  broblasts. 
  Unlike IPF, fi  broblast proliferation is self-limited during 
normal wound repair. To determine whether IPF fi  broblast 
proliferative properties were similar to or distinct from wound 
fi  broblasts, we examined wound fi  broblast proliferation on 
collagen matrices. Because primary human wound fi  broblasts 
were unavailable, we used mouse cutaneous wound fi  bro-
blasts. Similar to normal fi  broblasts, wound fi  broblast prolif-
eration was inhibited by polymerized collagen (  Fig. 1 C  ). 
These data suggest that the IPF fi  broblast phenotype is dis-
tinct from the wound fi  broblast phenotype. 
  Exposure of normal fi  broblasts to TGF-     for 24  –  48 h 
promotes diff  erentiation to a myofi  broblast phenotype (  27  ). 
We cultured normal lung fi  broblasts with TGF-     for 3  –  6 d 
and examined their proliferation on type I collagen matrices. 
Treatment of normal fi  broblasts with TGF-     inhibited their 
ability to proliferate on both monomeric and polymerized 
collagen (  Fig. 1 D  ). These data indicate that exposure of nor-
mal lung fi  broblasts to TGF-     for 3  –  6 d does not confer nor-
mal fi  broblasts with IPF fi  broblast proliferative properties. 
  To determine if this impairment of negative growth regu-
lation in IPF fi  broblasts was robust, we examined proliferation 
on polymerized collagen in defi  ned media containing peptide 
growth factors. Compared with control fi  broblasts, IPF fi  bro-
blasts displayed a signifi  cantly enhanced proliferative response 
(  Fig. 1 E  ). These data indicate that IPF fi  broblasts robustly re-
sist the negative proliferative eff  ects of polymerized collagen. 
  Phosphoinositide 3-kinase (PI3K)  –  Akt  –  S6K1 signaling 
in control fi  broblasts 
  To provide a context for our studies of IPF, we examined 
key signaling events regulating control fi  broblast proliferation 
on type I collagen. Our previous work strongly links fi  bro-
blast responses to     2    1 integrin  –  collagen interaction with 
    Figure 1.         IPF fi  broblasts display enhanced proliferation on poly-
merized collagen matrices.   (A) Proliferation assay of control (  n   = 8) and 
IPF (  n   = 6) fi  broblasts on monomeric and polymerized collagen. *, P   <   0.01 
and 0.005 for the ratio of proliferation of IPF fi  broblasts on polymerized 
versus monomeric collagen compared with control fi  broblasts at days 3 
and 6, respectively. (B) Quantifi  cation of DNA synthesis by BrdU incorpo-
ration in control (  n   = 4) and IPF (  n   = 5) fi  broblasts on monomeric and 
polymerized collagen at day 3. *, P   <   0.0001 for the percentage of BrdU-
positive IPF and control fi  broblasts at the indicated time. (C) Ratio of pro-
liferation of wound (  n   = 3) and IPF (  n   = 6) fi  broblasts on polymerized 
versus monomeric collagen at days 3 and 6 (*, P   <   0.02 and 0.001, respec-
tively). (D) Normal fi  broblasts were exposed to TGF-     for 3  –  6 d or left 
untreated, and cell numbers were quantifi  ed (*, P   <   0.05). (E) Proliferation 
assay of control (  n   = 4) and IPF (  n   = 5) fi  broblasts on monomeric and 
polymerized collagen in defi  ned media. Shown is the percent increase in 
cell number in response to the indicated growth factor treatment com-
pared with cultures continued in the absence of growth factors at day 3. 
*, P   <   0.05 or 0.001 for the proliferative response of IPF compared with 
control fi  broblasts at the time in defi  ned media containing insulin alone 
or insulin plus platelet-derived growth factor, respectively. Error bars rep-
resent SEM. Data are representative of three independent experiments.     JEM VOL. 205, July 7, 2008 
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by     2 or     1 blocking antibodies (  Fig. 2 C  ). There was no 
signifi  cant synergistic eff  ect on cell spreading using antibodies 
to     1,     3,     5, and     V in combination with     1 over using 
the     1 blocking antibody alone (  Fig. 2 C  ). These data dem-
onstrate that ligation of     2    1 by monomeric collagen is pri-
marily responsible for the activation of Akt when fi  broblasts 
attach to collagen. 
we used integrin blocking antibodies. Preincubation of con-
trol fi  broblasts with     2 or     1 blocking antibodies attenuated 
the increase in Akt phosphorylation in response to attach-
ment to monomeric collagen (  Fig. 2 B  ). Reagents blocking 
the     1,     3,     5, and     V integrin subunits were much less ef-
fective in inhibiting Akt activation. Consistent with this, cell 
spreading on monomeric collagen was signifi  cantly impaired 
    Figure 2.         PI3K  –  Akt  –  S6K1 signaling in control fi  broblasts.   (A) Western blot analysis of phospho-Akt and S6K1 in the absence or presence of the PI3K 
inhibitor wortmannin (WT) in response to control fi  broblast attachment to monomeric collagen in the absence of serum. One representative example is shown. 
(B) Western blot analysis of phospho-Akt in control fi  broblasts preincubated with the indicated integrin blocking antibody and plated on monomeric collagen. 
(C) Fibroblasts were plated on tissue culture plates coated with monomeric collagen and blocked by BSA. Cells were allowed to spread for 30 min. Cell areas of 
a random 150 cells were quantifi  ed by tracing the cell border using ImageJ software (available at http://rsb.info.nih.gov/ij/). (D) Western blot analysis of phos-
pho-Akt and S6K1 in response to control fi  broblast attachment to polymerized collagen in the absence of serum. (E) Western blot analysis of phospho-Akt and 
S6K1 in control fi  broblasts cultured on monomeric or polymerized collagen in growth factor  –  replete media. One representative example is shown. (F) GD25, 
GD25     1, and GD25    2  1  fi  broblasts were cultured on monomeric (left) or polymerized (right) collagen in the presence of serum, and cell numbers were 
quantifi  ed. (G) Proliferation assay of control fi  broblasts expressing dominant-negative Akt (Ad-DN-Akt; left) or constitutively active p110 subunit of PI3K (Ad-
PI3Kp110; right) and cultured on monomeric or polymerized collagen in growth factor  –  replete media, respectively. (top left) Western blot analyses of phospho- 
and total Akt. (bottom left) Shown is the percent change in cell growth. *, P   <   0.01 and 0.001 for the percent change in fi  broblast growth on monomeric 
collagen that was signifi  cantly less in control fi  broblasts expressing dominant-negative Akt compared with cells expressing control vector at days 3 and 6, 
respectively. (top right) Western blot analyses of phospho- and total Akt. (bottom right) Shown is the percent change in cell growth. *, P   <   0.01 and 0.0001 for 
the percent change in fi  broblast growth on polymerized collagen that was signifi  cantly greater in control cells expressing constitutively active p110 subunit of 
PI3K compared with control vector at days 3 and 6, respectively. Error bars represent SEM. Data are representative of three independent experiments.    1662 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
the eff  ect of enforced activation of PI3K on fi  broblast prolif-
eration on polymerized collagen. Enforced activation of PI3K 
by overexpression of the constitutively active p110 subunit of 
PI3K increased the level of phosphorylated Akt and enabled 
fi  broblasts to overcome the antiproliferative eff  ect of poly-
merized collagen (  Fig. 2 G  , right). These data demonstrate that 
the activity state of PI3K  –  Akt is a major component of the 
mechanism by which polymerized collagen negatively regu-
lates fi  broblast proliferation. 
  The PI3K  –  Akt  –  S6K1 pathway is pathologically regulated 
in IPF fi  broblasts 
  To characterize the PI3K  –  Akt  –  S6K1 signaling pathway in 
IPF fi  broblasts, we examined Akt and S6K1 after attachment 
of IPF fi  broblasts to monomeric collagen. Surprisingly, there 
was a muted increase in Akt and S6K1 phosphorylation com-
pared with control fi  broblasts (  Fig. 3 A  ).   We have previously 
shown that ligation of     1 integrin by the     1 integrin activat-
ing antibody TS2/16 increases Akt phosphorylation in nor-
mal fi  broblasts (  Fig. 3 B  , left) (  22  ) and, therefore, tested its 
eff  ect on Akt in IPF fi  broblasts. Ligation of     1 integrin by 
TS2/16 in IPF fi  broblasts failed to increase Akt phosphoryla-
tion (  Fig. 3 B  , right). These data indicate that IPF fi  broblast 
adhesion to monomeric collagen via     2    1 results in attenu-
ated activation of the Akt  –  S6K1 signal, a response opposite of 
control fi  broblasts. 
  The attenuation of Akt phosphorylation in IPF fi  bro-
blasts in response to ligation of     2    1 by collagen or     1 in-
tegrin activating antibody could result from a reduced level 
of integrin expression. However, we did not detect signifi  -
cant alterations in     1 integrin subunit expression in control 
compared with IPF fi  broblasts (unpublished data). Changes 
in the cytoplasmic domain of integrins can aff  ect the con-
formation of the extracellular domain. This mechanism is 
operational in normal cells and is termed inside-out signaling. 
To investigate the ligand binding/activation state of IPF fi  -
broblasts, we used the 9EG7 monoclonal antibody, which 
recognizes ligand-induced epitopes on the human     1 inte-
grin (  31, 32  ). FACS analysis of control and IPF fi  broblasts 
revealed that both fi  broblast lines bound comparable levels 
of 9EG7 antibody, indicating a similar     1 integrin activa-
tion state (  Fig. 3 C  ). Furthermore, full stimulation of     1 in-
tegrin in control and IPF fi  broblasts was obtained with the 
activating TS2/16 antibody. Therefore, the reduced level 
of Akt and S6K1 activation in response to ligation of     2    1 
by monomeric collagen could not be explained by altered 
    1 integrin expression or activation state. To confi  rm this, 
we examined focal adhesion kinase (FAK) phosphorylation. 
FAK is upstream of PI3K  –  Akt and can be used as a surro-
gate marker of integrin activation (  21  ). When serum-starved 
control and IPF fi  broblasts were plated on monomeric col-
lagen, the level of FAK tyrosine 397 phosphorylation was 
similar (  Fig. 3 D  ). 
  Current models for Akt regulation indicate that Akt 
phosphorylation is dependent on the activity of the upstream 
enzyme PI3K (  23  ). We examined PI3K activity in control 
  When we examined the eff  ect of fi  broblast attachment to 
polymerized collagen on the state of the PI3K  –  Akt  –  S6K1 
pathway, the pattern of signaling diff  ered from that observed 
on monomeric collagen. The level of phosphorylated Akt 
increased modestly when fi  broblasts attached to polymerized 
collagen (  Fig. 2 D  ), but S6K1 did not become phosphory-
lated. These fi  ndings indicate that compared with monomeric 
collagen, the amplitude of the PI3K  –  Akt  –  S6K1 signaling path-
way on polymerized collagen is attenuated. 
  After attachment to the matrix in the presence of growth 
factors, cells enter the cell cycle and proliferate. To exam-
ine the relationship between matrix state (polymerized vs. 
monomeric collagen) and the PI3K  –  Akt  –  S6K1 pathway 
during log-phase growth, control fi  broblasts were cultured 
on monomeric or polymerized collagen in the presence of 
serum for 3 d. Akt and S6K1 phosphorylation were main-
tained during fi  broblast proliferation on monomeric colla-
gen. In contrast, the levels of phosphorylated Akt and S6K1 
were suppressed on polymerized collagen (  Fig. 2 E  ). In the 
aggregate, these data show a tight relationship between ma-
trix chemistry and activity of the PI3K  –  Akt  –  S6K1 pathway 
in control fi  broblasts. 
  We have found that fi  broblasts use     2    1 to attach to col-
lagen during the adhesion assay (serum-free conditions), and 
that this is associated with modulation of the PI3K –  Akt  –  S6K1 
signal. However, during the proliferation assay the cells are 
cultured in serum and may interact with other extracellular 
matrix molecules, such as fi  bronectin, in addition to collagen. 
To examine which integrin receptors regulate fi  broblast pro-
liferation on collagen matrices, we performed our prolifera-
tion assay using GD25     2    1 integrin  –  null fi  broblasts (GD25 
cells) and GD25 cells reconstituted with     1 (GD25     1A) or 
    2    1 integrin (GD25     2    1A). GD25-null cells do not ex-
press     1 integrins, but they do express     v    3, which they use 
to attach to collagen. GD25     1 cells express some     1 inte-
grins, but not     2    1. GD25     2    1 cells express     2    1 (  28  –  30  ). 
We found that GD25-null cells proliferate poorly on mono-
meric collagen. Interestingly, GD25     1 cells were capable of 
proliferating on monomeric collagen as well as GD25 cells 
reconstituted with     2    1 (  Fig. 2 F  , left). In contrast, we found 
that only GD25     2    1 cells proliferated on polymerized col-
lagen (  Fig. 2 F  , right). Both GD25-null and GD25     1 cells 
proliferated poorly on polymerized collagen. Our data sug-
gest a scenario where, in addition to     2    1, other     1 integrins 
may contribute to proliferation signaling on monomeric col-
lagen, whereas     2    1 predominately regulates proliferation 
on polymerized collagen. 
  To examine whether matrix confi  guration, the PI3K  –
  Akt  –  S6K1 pathway, and fi  broblast proliferation were caus-
ally linked, we examined whether inhibiting PI3K using a 
dominant-negative Akt construct would attenuate fi  broblast 
proliferation on monomeric collagen. Kinase-dead dominant-
negative Akt decreased phosphorylated Akt and suppressed 
fi  broblast proliferation on monomeric collagen (48% in-
hibition of proliferation at day 6 compared with fi  broblasts 
treated with empty vector;   Fig. 2 G  , left). We also analyzed JEM VOL. 205, July 7, 2008 
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and IPF fi  broblasts by examining the amounts of phosphati-
dylinositol 3-phosphate produced in response to ligation of 
    1 integrin by the TS2/16 activating antibody. PI3K activity 
    Figure 3.         The PI3K  –  Akt  –  S6K1 pathway is pathologically regulated in IPF fi  broblasts.   (A) Western blot analyses of phospho-Akt and S6K1 in response 
to IPF fi  broblast attachment to monomeric collagen in the absence of serum. One representative example is shown. (B) Western blot analysis of phospho- and 
total Akt in response to treatment of control and IPF fi  broblasts with TS2/16     1 integrin activating antibody. (C) Control (  n   = 3) or IPF (  n   = 3) fi  broblasts were 
stained with anti  –      1 integrin antibodies and analyzed by FACS. Anti  –      1 integrin antibodies used were against ligand-induced binding sites (9EG7), activating 
sites (TS2/16), or total     1 integrin regardless of activation state (P5D2). (D) Control and IPF fi  broblasts were plated on monomeric collagen. Shown is a Western 
blot analysis of phosphorylated FAK (tyr397). Data are representative of three independent experiments from one control and one IPF cell line. (E) PI3K activity 
in control and IPF fi  broblasts plated on tissue culture dishes and treated with TS2/16     1 integrin activating antibody. Data are representative of three indepen-
dent experiments from one IPF cell line. (F) Western blot analysis of phospho-Akt and S6K1 in response to IPF fi  broblast attachment to polymerized collagen. 
One representative example is shown. (G) Western blot analysis of phospho-Akt in IPF fi  broblasts preincubated with the indicated integrin blocking antibody 
and plated on polymerized collagen. Data are representative of three independent experiments from one representative IPF cell line. (H) Western blot analysis of 
phospho-Akt and S6K1 in IPF fi  broblasts cultured on monomeric or polymerized collagen in growth factor  –  replete media. Data are representative of three inde-
pendent experiments from fi  ve IFP cell lines. (I) Proliferation assay of IPF fi  broblasts expressing dominant-negative Akt (left) or treated with 100 nM rapamycin 
(right) and cultured on polymerized collagen in growth factor  –  replete media. Shown is the percent change in cell growth. *, P   <   0.01 and 0.0001 for the percent 
change in cell growth on polymerized collagen that was signifi  cantly less in IPF fi  broblasts expressing dominant-negative Akt at days 3 and 6, respectively; or 
P   <   0.002 or 0.001 for the percent change in cell growth on polymerized collagen that was signifi  cantly less in IPF fi  broblasts treated with rapamycin at days 3 or 
6, respectively. Error bars represent SEM. Data are representative of three independent experiments from one IPF cell line. (J) IPF fi  broblasts were preincubated 
with the indicated integrin blocking antibody and plated on polymerized collagen in growth factor  –  replete media in the presence of antibody. BrdU staining as 
a measure of DNA synthesis was assessed at 24 h. Error bars represent SEM. Data are representative of three independent experiments from three IPF cell lines.    
was reduced in IPF fi  broblasts treated with TS2/16 antibody 
compared with control (  Fig. 3 E  ). This suggests that the 
decreased level of Akt and S6K1 phosphorylation seen in 1664 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
fi  broblasts on collagen, we examined PTEN protein ex-
pression when fi  broblasts were cultured on monomeric and 
polymerized collagen in the presence of serum. As a function 
of time, control fi  broblast PTEN expression decreased on 
monomeric collagen and increased on polymerized collagen 
(  Fig. 4 A  ), whereas in IPF fi  broblasts PTEN expression was 
invariant (  Fig. 4 B  ).   However, total PTEN protein levels in 
IPF fi  broblasts on polymerized collagen were modestly lower 
compared with monomeric collagen. Because the abundance 
of PTEN protein in IPF fi  broblasts was only modestly de-
creased, it remained unclear whether fi  broblast interaction 
with polymerized collagen was associated with a decrease in 
PTEN activity. 
  To assess PTEN activity, IPF and control fi  broblasts were 
cultured on collagen, PTEN was immunoprecipitated, and 
activity was quantifi  ed. Fibroblasts in uninjured tissue have a 
low proliferation rate. To provide a reference value for PTEN 
activity under proliferation-prohibitive conditions, PTEN ac-
tivity was measured in quiescent cultures of serum-starved 
  fi  broblasts. We then compared fi  broblast PTEN activity on 
monomeric and polymerized collagen in the presence of se-
rum growth factors with PTEN activity under proliferation-
prohibitive conditions. In control fi  broblasts, PTEN activity 
under proliferation-prohibitive condition was high. When 
these fi  broblasts were cultured on monomeric collagen in the 
presence of serum  —  a condition associated with active prolif-
eration  —  there was a signifi  cant decrease in PTEN activity 
(  Fig. 4 C  , left), whereas on polymerized collagen  —  which re-
presses proliferation  —  PTEN activity gradually increased over 
3 d to the level seen under proliferation-prohibitive condi-
tions. When IPF fi  broblasts were cultured under prolifera-
tion-prohibitive conditions, PTEN activity was high, similar 
to control cells (  Fig. 4 D  , left). However, when we examined 
PTEN activity on polymerized to monomeric collagen, the 
response was opposite to that of control fi  broblasts. There 
was a sharp decrease in PTEN activity on polymerized com-
pared with monomeric collagen (  Fig. 4 D  , left). To confi  rm 
these results, we examined PI3K activity in control and IPF 
fi  broblasts by examining the amounts of phosphatidylinositol 
3-phosphate produced in response to culture on collagen. 
When control fi  broblasts were cultured on polymerized col-
lagen, the level of PI3K activity decreased 19% compared with 
monomeric collagen (  Fig. 4 C  , right). In contrast, the level of 
PI3K activity increased 45% when IPF fi  broblasts were cul-
tured on polymerized collagen (  Fig. 4 D  , right). These data 
indicate that in response to polymerized collagen, IPF fi  bro-
blasts display inappropriately low PTEN function and con-
comitant activation of Akt and proliferation. 
  Recent work suggests that cytosolic PTEN needs to be 
recruited to the plasma membrane, where it is activated and is 
then in the right location to inhibit PI3K  –  Akt (  35, 36  ). Thus, 
total PTEN levels may not correlate well with activity. To 
address this issue, we analyzed the levels of membrane-associ-
ated PTEN from control and IPF fi  broblasts cultured on po-
lymerized collagen. IPF fi  broblast membrane  –  associated PTEN 
was markedly decreased compared with controls (  Fig. 4 E  ). 
response to ligation of     1 integrin by monomeric collagen or 
activating antibody in IPF fi  broblasts is caused by a reduced 
level of PI3K activity. 
  Having seen aberrant activity of the PI3K  –  Akt  –  S6K1 
signaling pathway in IPF fi  broblasts attaching to mono-
meric collagen, we examined the pathway after attachment 
to polymerized collagen. In contrast to control fi  broblasts, 
we found that both Akt and S6K1 became phosphorylated 
when IPF fi  broblasts attached to polymerized collagen (  Fig. 
3 F  ). The increase in Akt phosphorylation was largely in-
hibited by blocking antibodies to the     2 and     1 integrin 
subunits, indicating that activation of Akt in response to 
IPF fi  broblast adhesion to polymerized collagen is mediated 
through     2    1 (  Fig. 3 G  ). 
  We next examined the eff  ect of matrix state on the 
PI3K  –  Akt  –  S6K1 pathway on actively proliferating IPF fi  -
broblasts. In contrast to the pattern observed in control fi  bro-
blasts, we found that the levels of phosphorylated Akt and 
S6K1 were elevated when IPF fi  broblasts were cultured on 
polymerized collagen (  Fig. 3 H  ), indicating that the PI3K 
pathway was aberrantly activated. These data are consistent 
with the idea that IPF fi  broblasts elude the antiproliferative 
eff  ects of polymerized collagen by aberrantly activating the 
PI3K  –  Akt  –  S6K1 signaling pathway. 
  To test this directly, we inhibited the PI3K  –  Akt path-
way by infecting IPF fi  broblasts with an adenoviral vector 
containing a dominant-negative Akt construct and exam-
ined proliferation on polymerized collagen. Kinase-dead 
Akt decreased fi  broblast proliferation on polymerized colla-
gen by     50% compared with empty vector (  Fig. 3 I  , left). 
Consistent with this, inhibition of the downstream Akt ef-
fectors mammalian target of rapamycin and S6K1 by rapa-
mycin reversed the aberrant proliferation of IPF fi  broblasts 
on polymerized collagen (  Fig. 3 I  , right). The ability of IPF 
fi  broblasts to circumvent the negative regulatory eff  ects of 
polymerized collagen is caused by aberrant activation of the 
PI3K  –  Akt  –  S6K1 pathway. 
  Similar to control fi  broblasts, IPF fi  broblasts use     2    1 to 
attach to polymerized collagen. To address which integrins 
IPF fi  broblasts use for proliferation signaling on polymerized 
collagen, we cultured IPF fi  broblasts pretreated with integrin 
blocking antibodies on polymerized collagen in the presence 
of serum. At 24 h, we analyzed BrdU staining as a measure of 
DNA synthesis.     2 and     1 blocking antibodies attenuated 
BrdU staining compared with IgG control (  Fig. 3 J  ). Other 
blocking antibodies had minimal eff  ect on DNA synthesis. 
Thus, IPF fi  broblasts predominantly use     2    1 for prolifera-
tion signaling on polymerized collagen. 
  Regulation of the tumor suppressor PTEN is altered 
in IPF fi  broblasts 
  PTEN phosphatase negatively regulates integrin growth sig-
naling by inhibiting Akt (  33, 34  ). PTEN activity is deter-
mined by its abundance and phosphorylation state (  35  –  38  ). 
To determine if changes in PTEN expression were associ-
ated with the altered signaling and growth response of IPF JEM VOL. 205, July 7, 2008 
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  S6K1 and maintenance of high PTEN activity, we examined 
whether down-regulation of PTEN would enable control fi  -
broblasts to overcome the antiproliferative eff  ects of poly-
merized collagen. Control fi  broblasts were transfected with 
PTEN or control siRNA and plated on polymerized colla-
gen. PTEN siRNA knocked down PTEN expression (  Fig. 5, 
A and B  ) and augmented their ability to proliferate on poly-
merized collagen compared with control (  Fig. 5 C  ).   
This suggests that an inadequate recruitment of cytosolic PTEN 
to the membrane may account for inappropriately low PTEN 
activity in IPF fi  broblasts on polymerized collagen. 
  Ectopic expression of PTEN in IPF fi  broblasts reverses 
the abnormal proliferative phenotype 
  Because inhibition of control fi  broblast proliferation on po-
lymerized collagen is associated with suppression of PI3K  –  Akt  –
    Figure 4.         Regulation of PTEN is altered in IPF fi  broblasts.   (A and B) Western blot analysis of total PTEN in control (A) or IPF (B) fi  broblasts cultured on 
monomeric or polymerized collagen in growth factor  –  replete media. One representative sample out of fi  ve control and fi  ve IPF cell lines examined is shown. 
(C and D) PTEN phosphatase assay showing the percent change in PTEN activity in control (  n   = 3; C, left) or IFP (  n   = 3; D, left) fi  broblasts cultured on polymer-
ized or monomeric collagen in growth factor  –  replete media compared with cells cultured under proliferation-prohibitive conditions. *, P   <   0.001 for PTEN 
activity in control fi  broblasts on polymerized collagen that was signifi  cantly higher at day 3 compared with monomeric collagen; P   <   0.01 for PTEN activity in 
IPF fi  broblasts on polymerized collagen that was signifi  cantly less on day 3 compared with monomeric collagen. Shown is PI3K activity in control (C, right) 
and IPF (D, right) fi  broblasts cultured on monomeric or polymerized collagen in growth factor  –  replete media for 3 d. *, P   <   0.005 for PI3K activity in control 
fi  broblasts cultured on polymerized collagen that was signifi  cantly less at day 3 compared with monomeric collagen; or P   <   0.05 for PI3K activity in IPF fi  bro-
blasts cultured on polymerized collagen that was signifi  cantly higher at day 3 compared with monomeric collagen. Error bars represent SEM. (E) PTEN protein 
levels in membrane and cytosolic fractions of cell lysates were measured by Western blot analysis. Data are representative of three independent experiments.    1666 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
blasts cultured on polymerized collagen (  Fig. 6 C  ). Thus, el-
evation of PTEN activity in IPF fi  broblasts restores the normal 
pattern of proliferation on polymerized collagen, whereas 
pathologically low PTEN activity can account for the ability 
of IPF fi  broblasts to circumvent the antiproliferative eff  ects of 
polymerized collagen. 
  Can PTEN defi  ciency lead to a more durable 
fi  broproliferative response after tissue injury? 
  To address this issue, we used PTEN haploinsuffi   cient mice. 
Using a well-characterized cutaneous wound model, a 2  ×   2 –  cm 
skin wound was made on the middorsal surface of PTEN 
wild-type or haploinsuffi   cient mice (  39  ). We measured the 
reduction in wound surface area by planimetry as a function 
of time. There was an     10-fold greater reduction in wound 
surface area of PTEN wild-type compared with haploinsuffi   -
cient mice at day 28 after wounding (  Fig. 7 A  ), indicating that 
wound repair was delayed in PTEN-defi  cient mice.   
  We performed histological analysis of the wounds as a 
function of time. We focused our analysis at days 18 and 28, 
as large diff  erences in granulation tissue size were apparent at 
these times. Histological analysis of day 18 wounds revealed 
markedly increased cellularity of the granulation tissue of 
PTEN haploinsuffi   cient (  Fig. 7 B  , top left) compared with 
wild-type mice (  Fig. 7 B  , top right). We sought to determine 
why the granulation tissue of PTEN haploinsuffi   cient mice 
displayed increased cellularity. We reasoned that it could be 
caused by enhanced proliferation, reduced apoptosis, or both. 
We used Ki67 staining as a marker of proliferation. Abundant 
Ki67 staining was present both in day 18 wound granulation 
tissue and in the newly formed epithelium overlying the 
wound ulcer in PTEN haploinsuffi   cient mice (  Fig. 7 B  , mid-
dle left). There was little Ki67 staining in the granulation tissue 
of PTEN wild-type mice, whereas the overlying regenerating 
epithelium stained positive (  Fig. 7 B  , middle right). Immuno-
histochemical analysis of PTEN haploinsuffi   cient granulation 
tissue revealed the presence of abundant       –  smooth muscle 
actin  –  expressing mesenchymal cells (  Fig. 7 B  , bottom right). 
  To determine whether decreased PTEN activity accounted 
for the enhanced proliferation of IPF fi  broblasts on polymer-
ized collagen, we infected IPF fi  broblasts with an adenoviral 
vector containing wild-type PTEN. This elevated PTEN ex-
pression and suppressed phospho-Akt (  Fig. 6 A  ).   Ectopic 
PTEN also inhibited two downstream targets of the PI3K  –
  Akt pathway, S6K1 and translation initiation factor eIF4F 
(  Fig. 6, A and B  ), and inhibited DNA synthesis in IPF fi  bro-
    Figure 5.         Knockdown of PTEN enables control fi  broblasts to elude 
the antiproliferative effects of polymerized collagen.   Control  fi  bro-
blasts were transfected with PTEN or control siRNA and cultured on 
polymerized collagen in serum. (A) Western blot analysis of total PTEN 
levels. (B) Western blot analysis showing PTEN protein expression in re-
sponse to increasing concentrations of PTEN siRNA. (C) Proliferation 
assay of control fi  broblasts on polymerized collagen in serum-replete 
media. After 6 d, there was a signifi  cant increase in proliferation on po-
lymerized collagen in cells treated with PTEN siRNA compared with con-
trol siRNA (*, P   <   0.04). Error bars represent SEM. Data are representative 
of three independent experiments.     
    Figure 6.         Ectopic expression of PTEN in IPF fi  broblasts reverses the abnormal proliferative phenotype.   (A) Western blot analysis of total PTEN and 
phospho-Akt and S6K1 in IPF fi  broblasts expressing wild-type PTEN (Ad-wtPTEN) or empty vector (Ad-GFP) and cultured on polymerized collagen in growth 
factor  –  replete media. (B) eIF4F activity (RLUC luminescence) in IPF fi  broblasts expressing wild-type PTEN or control vector and cultured for 3 d on polymerized 
collagen. *, P   <   0.0001 for signifi  cantly less eIF4F activity in IPF fi  broblasts expressing wild-type PTEN compared with control. (C) Quantifi  cation of DNA synthe-
sis by BrdU incorporation in IPF fi  broblasts expressing wild-type PTEN or empty vector and cultured on polymerized collagen in growth factor  –  replete media for 
3 d. Shown is the percentage of BrdU-positive IPF fi  broblasts. *, P   <   0.0001 for the percentage of BrdU-positive IPF fi  broblasts expressing wild-type PTEN that 
was signifi  cantly less compared with control. Error bars represent SEM. Data are representative of three independent experiments from one IPF cell line.    JEM VOL. 205, July 7, 2008 
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We also analyzed apoptosis in the granulation tissue of PTEN 
wild-type and haploinsuffi   cient mice by examining cleaved 
caspase 3 expression. No diff  erences in cleaved caspase 3 stain-
ing were apparent (unpublished data). For controls, no immuno-
reactivity was seen when IgG isotype control antibodies were 
substituted for the primary antibody (unpublished data). These 
data suggest that a more durable fi  broproliferative response 
accounts for the abundance of       –  smooth muscle actin  –  ex-
pressing myofi  broblasts and the delayed resorption of granu-
lation tissue in PTEN-defi  cient mice after tissue injury. 
  PTEN-defi  cient mice have increased fi  brosis 
after bleomycin-induced lung injury 
  To examine the eff  ect of PTEN defi  ciency on the develop-
ment of pulmonary fi  brosis, PTEN haploinsuffi   cient or wild-
type mice were given bleomycin intratracheally, and collagen 
content was analyzed by Sircol assay 21 d later. The collagen 
content of PTEN-defi  cient mice was increased 55% com-
pared with wild-type mice (11.12   ±   3.42   μ  g/g vs. 17.25   ±   
2.47   μ  g/g body weight; P   <   0.005;   Fig. 8 A  ).   Collagen de-
position in the mice was evaluated by Trichrome staining. 
Consistent with the Sircol assay, PTEN-defi  cient mice dis-
played augmented collagen deposition after bleomycin com-
pared with wild-type mice (  Fig. 8 B  , middle and bottom). 
Collectively, our in vivo studies indicate that PTEN defi  -
ciency is associated with a more durable fi  broproliferative re-
sponse leading to exaggerated fi  brosis. 
  Akt is activated in the fi  broblastic foci of human IPF tissue 
  Our in vitro experiments indicate that the Akt  –  S6K1 pathway 
is aberrantly activated in IPF fi  broblasts cultured on polymer-
ized collagen. To analyze the activation state of Akt in IPF 
lung tissue in vivo, we performed immunohistochemistry on 
lung tissue from fi  ve IPF patients examining phospho-Akt ex-
pression. Consistent with our in vitro studies, phospho-Akt  –
  positive cells were present in the fi  broblastic foci of IPF tissue 
(image is representative of fi  brotic foci from the four other 
patient samples;   Fig. 9 C  ).   In contrast, although the epithelium 
and endothelium of normal lung tissue stained positive for 
phospho-Akt, no phospho-Akt could be detected in the mes-
enchymal or smooth muscle cells of normal lung parenchyma 
(  Fig. 9 A  ). As a control, when fi  brotic lung tissue was stained 
with an irrelevant primary antibody (anti-p53) plus secondary 
antibody, scant immunoreactivity was present (  Fig. 9 E  ). 
No immunoreactivity was seen when IPF and normal lung 
tissue were stained with secondary antibody without primary 
antibody (unpublished data). When we used an antibody that 
recognizes total PTEN, we found that PTEN expression was 
prominent in the epithelium, endothelium, and mesenchymal 
cells in normal lung tissue (  Fig. 9 B  ). PTEN expression could 
also be seen in cells in the fi  broblastic foci of IPF tissue (  Fig. 9 D  ). 
This is consistent with our in vitro fi  ndings, which demonstrate 
the presence of PTEN protein expression in IPF fi  broblasts 
cultured on collagen. It is important to note the limitations of 
the PTEN immunohistochemical studies. PTEN activity is 
dependent on both its expression and phosphorylation state. 
Double staining for Ki67 and       –  smooth muscle actin sug-
gested the presence of proliferating myofi  broblasts in the 
PTEN haploinsuffi   cient granulation tissue (  Fig. 7 B  , bottom 
left). By day 28, the wounds of PTEN-defi  cient mice were 
incompletely healed, whereas the wounds of the PTEN wild-
type mice were nearly completely healed. At this time, there 
was still a mild persistent proliferative response in PTEN-
  defi  cient compared with wild-type mice (unpublished data). 
    Figure 7.         PTEN defi  ciency leads to a more durable fi  broprolifera-
tive response after tissue injury.   (A) Shown is the surface area of 
granulation tissue in PTEN wild-type (+/+;   n   = 3) and haploinsuffi  cient 
(+/   ;   n   = 3) mice. There was a signifi  cant delay in the resolution of 
granulation tissue in PTEN +/     compared with +/+ mice (P   <   0.0001). 
Error bars represent SEM. (B) Hematoxylin and eosin  –  stained sections of 
granulation tissue at day 18 in PTEN +/     (top left) and +/+ (top right) 
mice. Note the increased cellularity of granulation tissue in PTEN +/    
mice. Ki67 staining of day 18 granulation tissue from PTEN +/     (middle 
left) and +/+ (middle right). Note the abundant Ki67-positive cells (nu-
clei brown) in the granulation tissue of PTEN +/     mice. Insets show 
positive Ki67 staining in the newly formed epithelium overlying the 
wound ulcer. (bottom right) Abundant     – smooth  muscle  actin  staining 
of the granulation tissue of PTEN +/     mice. (bottom left) Double stain-
ing for Ki67 (nuclei brown) and       –  smooth muscle actin. Bar, 50   μ  m.     1668 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
expansion of the fi  broblast focus by proliferating myofi  bro-
blasts depositing type I collagen leads to permanently scarred 
alveoli. Although recent studies indicate that IPF fi  broblasts 
display a distinct pathological phenotype (  6  –  12  ), the mecha-
nisms diff  erentiating IPF fi  broblasts from their normal coun-
terparts remain poorly understood. In this study, we present 
results providing direct evidence for defective negative regu-
lation of the proliferative pathway in IPF fi  broblasts that support 
the theory that the pathogenesis of IPF involves abnormalities 
in the fi  broblast cellular machinery. 
  When cells attach to the extracellular matrix, a matrix rec-
ognition signal is generated by integrin  –  ligand binding. This 
is termed   “  outside-in signaling  ”   and activates specifi  c signal 
transduction pathways that regulate cell function. In the case of 
normal fi  broblasts, ligation of     1 integrin by monomeric col-
lagen generates a matrix recognition signal characterized by an 
increase in Akt and S6K1 activity in a PI3K-dependent man-
ner. Facilitating this increase in Akt and S6K1 activity is a re-
laxation in the suppressive activity of PTEN. PTEN is a tumor 
suppressor phosphatase and a major inhibitor of the PI3K  –  Akt 
pathway whose baseline activity is believed to be constitutively 
high (  21  ). In this study, we demonstrate that a relaxation of 
PTEN  ’  s suppressive activity supports normal fi  broblast prolif-
eration on monomeric collagen. In contrast, seminal studies 
have demonstrated that polymerized collagen functions as a 
negative regulator of fi  broblast proliferation by promoting ar-
rest in the G1 phase of the cell cycle (  15  ). We show that normal 
fi  broblast interaction with polymerized collagen via     1 inte-
grin, which is the physiological form of collagen that fi  broblasts 
interact with, results in high PTEN activity, causing suppres-
sion of the PI3K  –  Akt  –  S6K1 pathway and proliferation. Thus, 
the contact of fi  broblasts with polymerized collagen provides a 
physiological mechanism to limit excess fi  broproliferation. 
  It is important to note that for our in vitro studies, the 
critical comparison was between proliferation signaling in con-
trol and IPF fi  broblasts on polymerized collagen. In contrast to 
control fi  broblasts where high PTEN activity inhibits PI3K  –
  Akt, we have discovered that in IPF fi  broblasts,     1 integrin 
interaction with polymerized collagen generates an aberrant 
matrix recognition signal characterized by activated Akt  –
  S6K1 activity because of inappropriately low PTEN activity. 
Importantly, using PTEN haploinsuffi   cient mice and two in 
vivo models of tissue injury, a well characterized cutaneous 
wound healing model and bleomycin-induced lung injury, 
we confi  rm that a defi  ciency in PTEN activity results in a 
more durable fi  broproliferative response after tissue injury and 
leads to pathological fi  brosis. 
  PTEN activity is a function of abundance and phosphory-
lation state (  35  –  38, 40  ). Current models for PTEN activation 
suggest that cytosolic PTEN is recruited to the plasma mem-
brane, where it is activated by dephosphorylation. Membrane-
associated PTEN is then in the right location to inhibit PI3K 
(  35, 36  ). Our data indicate that PTEN activity is inappropri-
ately low in IPF fi  broblasts in response to integrin-polymerized 
collagen interaction. We have found that membrane-associated 
PTEN is decreased in IPF fi  broblasts compared with controls. 
Analyzing total PTEN expression may not accurately refl  ect 
PTEN activity. Thus, it remains unclear whether PTEN activ-
ity is altered in vivo in IPF. Nevertheless, consistent with our 
in vitro fi  ndings that the Akt pathway is aberrantly activated in 
IPF fi  broblasts, these data verify that Akt is activated in vivo 
in IPF fi  broblastic foci. 
    DISCUSSION   
  The pathogenesis of IPF remains incompletely understood. 
However, prima facie evidence for a key role for the fi  bro-
blast in IPF is established by the observation that progressive 
    Figure 8.         PTEN defi  ciency exaggerates fi  brosis after lung injury.   PTEN 
+/     or +/+ mice were administered bleomycin intratracheally. (A) 21 d later, 
lungs were harvested and total lung collagen was determined by Sircol assay 
(  n   = 6 mice per group). (B) Hematoxylin and eosin (H  & E) – stained  sections  of 
day 21 lung tissue in PTEN +/     (top left) and +/+ (top right) mice. Trichrome 
staining of day 21 lung tissue from PTEN +/     (left, middle and bottom) and 
+/+ (right, middle and bottom) mice. Results are representative of three mice 
per group. Bars: (top and middle) 200   μ  m; (bottom) 50   μ  m.    JEM VOL. 205, July 7, 2008 
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pared with normal fi  broblasts when they are cultured on po-
lymerized collagen matrices, and that this is associated with 
reduced membrane-associated PTEN. Thus, our data do not 
link IPF with a defi  ciency of PTEN protein expression. Rather, 
our studies provide direct mechanistic evidence that the patho-
logical ability of IPF fi  broblasts to elude the antiproliferative 
properties of polymerized collagen is caused by defective regu-
lation of PTEN function in response to their interaction with 
collagen via integrin. 
  A central unresolved issue in IPF has revolved around the 
question of whether IPF fi  broblasts are normal fi  broblasts that 
behave abnormally because they reside in a microenvironment 
consisting of profi  brotic cytokines or whether they have ac-
quired a distinct pathological phenotype that is stable and does 
not depend on continued exposure to profi  brotic molecules. 
Our study suggests that IPF fi  broblasts are not normal or wound 
fi  broblasts whose pathological behavior depends on continuous 
exposure to profi  brotic cytokines. Rather, IPF fi  broblasts have 
acquired a distinct stable pathological phenotype that persists 
despite an absence of profi  brotic cytokines. While our study 
was in progress, a study was published that may provide insight 
into how these cells have acquired this abnormal phenotype. 
This study demonstrated that when epithelial cells are chroni-
cally exposed to TGF-     (30 d), they undergo epithelial-
  mesenchymal transition (EMT) (  42  ). These cells display Akt 
phosphorylation that persists despite withdrawal of TGF-    . In 
addition, two recent studies suggest an EMT origin for IPF fi  -
broblasts (  43, 44  ). The implication of our work in the context 
of these studies suggests that IPF fi  broblasts may represent cells 
that have undergone EMT and have acquired a stable patho-
logical phenotype as part of the transdiff  erentiation process. In 
conclusion, our data demonstrate that the IPF fi  broblast phe-
notype is characterized by persistent activation of the PI3K  –  Akt 
pathway caused by inappropriately low PTEN activity that 
confers a pathological proliferative response with the capacity 
to elude the antiproliferative properties of fi  brillar collagen. 
  MATERIALS AND METHODS 
  Cell culture 
  Seven primary fi  broblast lines were established from IPF patients. Cells were 
obtained from lungs removed at the time of transplantation or death. The 
diagnosis of IPF was supported by history, physical examination, pulmonary 
function tests, and typical high resolution chest computed tomography fi  nd-
ings of IPF. In all cases, the diagnosis of IPF was confi  rmed by microscopic 
analysis of lung tissue and demonstrated the characteristic morphological 
fi  ndings of usual interstitial pneumonia. All patients fulfi  lled the criteria for 
the diagnosis of IPF as established by the American Thoracic Society and the 
European Respiratory Society (  45  ). Seven normal primary control adult hu-
man lung fi  broblast lines were used. One was purchased from American 
Type Culture Collection (human lung fi  broblast 210), and six were established 
from histologically normal lung tissue adjacent to carcinoid tumor (  n   = 5) or 
adjacent to radiation-induced fi  brotic lung tissue (  n   = 1). One diseased con-
trol primary human fi  broblast line was derived from a patient with chronic 
obstructive pulmonary disease at the time of lung transplantation. Primary 
lung fi  broblast lines were generated by explant culture and cultured in high 
glucose DMEM containing 10% FCS. Fibroblasts were used between pas-
sages fi  ve and eight. Cells were characterized as fi  broblasts as previously de-
scribed (  46  ). Use of human tissues was approved by the Institutional Review 
Board at the University of Minnesota. 
Our data suggest a scenario where in response to IPF fi  broblast 
interaction with polymerized collagen via integrin, there is de-
fi  cient recruitment of cytosolic PTEN to the membrane. This 
would result in a failure of PTEN to be activated. Inappro-
priately low PTEN activity would then facilitate aberrant acti-
vation of the PI3K  –  Akt signal and enable IPF fi  broblasts to elude 
the proliferative-suppressive eff  ects of polymerized collagen. 
  A previous study presented evidence that PTEN expression 
is low in IPF tissue compared with normal lung tissue suggest-
ing that a defi  ciency in PTEN expression is associated with 
pulmonary fi  brosis (  41  ). Our study off  ers a diff  erent explana-
tion for the role of PTEN in IPF. Unlike the fi  ndings in this 
previous study, we have not found that PTEN protein ex-
pression is decreased in IPF fi  broblasts compared with normal 
fi  broblasts during routine tissue culture. We have found that 
PTEN activity is inappropriately low in IPF fi  broblasts com-
    Figure 9.         Akt is activated in fi  brotic foci in IPF lung tissue.   Immuno-
histochemistry, evaluating phospho-Akt and total PTEN expression, was 
performed on lung tissue obtained from patients with histologically nor-
mal lungs (  n   = 5) and IPF (  n   = 5). (A and B) Normal lung tissue. Note the 
presence of phospho-Akt in epithelial and endothelial cells (A). No phos-
pho-Akt expression is apparent in mesenchymal cells in the vessel wall or 
in normal lung parenchyma in A. Arrows denote PTEN expression in spin-
dle-shaped cells within normal lung parenchyma (B). (C and D) IPF lung 
tissue. Note the phospho-Akt expression in spindle-shaped cells within 
the fi  brotic foci of IPF (C). Cells within fi  brotic foci also displayed PTEN 
expression (D). (E) As a control, shown is fi  brotic lung tissue stained with 
irrelevant primary antibody (anti-p53). Bars, 50   μ  m.     1670 PATHOLOGICAL INTEGRIN  –  PI3K  –  AKT  –  PTEN SIGNALING AXIS IN IPF   | Xia et al. 
(Ki67 [Abcam]; anti  –  cleaved caspase 3 [Cell Signaling Technology]; and 
      –  smooth muscle actin [Vector Laboratories]). 
  Bleomycin model of lung injury 
  Mice were anesthetized with sodium pentobarbital. 0.05 U bleomycin dis-
solved in sterile saline was instilled into the trachea. Lungs were harvested on 
day 21 after bleomycin. Total lung collagen levels were determined in both 
lungs by Sircol assay according to the manufacturer  ’  s instructions (Accurate). 
  Immunohistochemistry 
  Immunohistochemical studies were performed on frozen sections prepared 
from lung specimens obtained from patients undergoing lung transplanta-
tion for IPF (  n   = 5), and from surgical specimens showing normal lung 
  parenchyma distant from tumor nodule (  n   = 5). The avidin  –  biotin com-
plex immunoperoxidase technique was used. Primary antibodies included 
phospho-Akt (ser473; Cell Signaling Technology) and total PTEN (6H2.1; 
Cascade Bioscience). 
  Data analysis 
  Comparisons of data among each experiment were performed with the uni-
polar unpaired or paired Student  ’  s   t   test. All experiments were replicated a 
minimum of three times. Data are expressed as mean   ±   SD. P   <   0.05 were 
considered signifi  cant. 
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